Loading...
You are here:  Home  >  Health  >  Current News

Novartis’s LEE011 gets FDA fast track in advanced breast cancer



ZURICH (Reuters) - The U.S. Food and Drug Administration has granted priority review status for Novartis drug LEE011 (ribociclib) as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in combination with letrozole, the Swiss drugmaker said on Tuesday.


Other News

Chipotle to shut outlets next month for food safety meeting (Reuters) - Popular burrito chain Chipotle Mexican Grill Inc will close its restaurants for a few hours next month to hold a meeting on food safety ...
Early ultrasounds may not detect microcephaly in mothers with Zika: study CHICAGO (Reuters) - Three ultrasounds done in the early weeks of pregnancy in a Finnish woman living in the United States infected by Zika failed to...
Teens’ view of pot changed in one state after legalization (Reuters Health) - After marijuana was legalized for adults in the U.S. state of Washington, younger teens there perceived it to be less harmful and...

Found news:

Loading...

You might also like...

Philip Morris International CEO cheers U.S. FDA tobacco proposal

Read More →